This is another medtech name that has been a laggard for a while, and is now gaining legs after the VHA contract announcement.

Technically, there has been good follow through, and the price has punched through a couple of resistance levels (which have held in the past couple of attempts) to sit at a new 52w high. Looks promising. Significant overhead resistance does exist around $1, and also at $1.20-25.